TOP SCEINCE7 months ago
A trial HIV vaccine triggered elusive and essential antibodies in humans
An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small...